Company / Profit Margin
Insight Molecular Diagnostics Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3225.0%
FY2025
5-year range
-7609.8% / -1848.4%
FY2021-FY2025
Trend
-74.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -7609.8% to -3225.0% over the past 2 years.
Based on SEC 10-K filings.
-3225.0% in FY2025 with a 5-year CAGR of -1380.8%.
Improved from -7609.8% to -3225.0% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -308.9pp
- 5-Year Change
- -1380.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 74.5% year-over-year.
- Peak profit margin was recorded in FY2020.
- Lowest profit margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3225.0% | -74.5% |
| FY2024 | -1848.4% | +75.7% |
| FY2023 | -7609.8% | -161.0% |
| FY2022 | -2916.2% | -18.5% |
| FY2021 | -2461.5% | -33.5% |
| FY2020 | -1844.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026